Apple Hospitality REIT Reports Results of Operations for First Quarter 2024
RICHMOND, Va.–(BUSINESS WIRE)–Apple Hospitality REIT, Inc. (NYSE: APLE) (the “Company” or “Apple Hospitality”) today announced results of operations... Read more.
ProAssurance Reports Results for First Quarter 2024
BIRMINGHAM, Ala.–(BUSINESS WIRE)–ProAssurance Corporation (NYSE: PRA) reports net income of $4.6 million, or $0.09 per diluted share, and operating income(1)... Read more.
Finance of America Reports First Quarter 2024 Results
– Net loss from continuing operations of $16 million or $0.06 basic loss per share for the quarter – – Third consecutive quarter of improved operating results... Read more.
IFF Reports First Quarter 2024 Results
NEW YORK–(BUSINESS WIRE)–$IFF–IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Consolidated... Read more.
Vizient/AACN Nurse Residency Program announces integration of Maryland R3 curriculum
IRVING, Texas–(BUSINESS WIRE)–The Vizient/American Association of College Nursing (AACN) Nurse Residency Program™ announced today the integration of... Read more.
Ambac Reports First Quarter 2024 Results
NEW YORK–(BUSINESS WIRE)–Ambac Financial Group, Inc. (NYSE: AMBC) (“Ambac” or “AFG”), a financial services holding company, today... Read more.
Compact Without Compromise: CORSAIR Unveils the CORSAIR ONE i500 PC
MILPITAS, Calif.–(BUSINESS WIRE)–$CRSR–CORSAIR® (Nasdaq: CRSR) today announced the launch of the CORSAIR ONE i500 PC, a compact powerhouse packed... Read more.
Zuora Announces Date for Its First Quarter Fiscal 2025 Earnings Conference Call
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced that it will report financial... Read more.
Mastercard to Participate in Upcoming Investor Conferences
PURCHASE, N.Y.–(BUSINESS WIRE)–Mastercard Incorporated (NYSE: MA) today announced its participation in the following investor conferences in the month... Read more.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Anticipates Reporting Topline Data from EDP-323 Respiratory Syncytial Virus (RSV) Challenge Study in Q3 2024 and Phase 2 Study of Zelicapavir in Pediatric RSV Patients... Read more.